American Pharmaceutical Partners have announced that its cancer-fighting drug Abraxane has demonstrated greater tumour reduction and fewer side effects when compared to a solvent-dissolved equivalent....
http://www.azonano.com/article.aspx?ArticleID=775 | 20 Apr 2004
Inc. (NASDAQ:ABII), a fully integrated global biotechnology company dedicated
to the discovery, development and delivery of next-generation therapeutics and
http://www.azonano.com/news.aspx?newsID=11817 | 1 Jun 2009
Paclitaxel is a powerful anticancer agent used to treat a variety of malignancies,
but severe side effects limit its ultimate effectiveness and utility. To improve
http://www.azonano.com/news.aspx?newsID=7842 | 27 Sep 2008
University chemists have discovered a way to load dozens of
molecules of the anti-cancer drug paclitaxel onto tiny gold spheres.
The result is a tiny ball, many times smaller than a living...
http://www.azonano.com/news.aspx?newsID=4934 | 13 Sep 2007
Vascular Nanotransfer Technologies (“VNT”), an emerging medical technology company, announced today that large animal model in vivo tests of its paclitaxel nanocarrier-based Drug Coated Balloon...
http://www.azonano.com/news.aspx?newsID=25775 | 20 Oct 2012
By Cameron Chai
Decision Resources, a research and consultative firm for pharmaceutical and healthcare issues, offers analysis on the latest developments in the non-small-cell lung cancer drug...
http://www.azonano.com/news.aspx?newsID=24586 | 30 Mar 2012
By Cameron Chai
A research study by Jeffrey Myers from the University of Texas MD Anderson Cancer Center and James Tour from the Rice University has reported that a combination of carbon...
http://www.azonano.com/news.aspx?newsID=24307 | 18 Feb 2012
When loaded with an anticancer drug, a delivery system based on a novel material
that its creators call a nanosponge is three to five times more effective at
reducing tumor growth than direct...
http://www.azonano.com/news.aspx?newsID=18587 | 16 Jul 2010
Abraxis BioScience, Inc.
(NASDAQ:ABII), a fully integrated, global biotechnology company, today announced
the launch in Germany of ABRAXANE, 5 mg/ml powder for suspension for infusion...
http://www.azonano.com/news.aspx?newsID=9741 | 4 Feb 2009
Too often, patients with ovarian cancer or mesothelioma develop metastases
that spread within the abdominal cavity, and when that occurs, the chances of
surviving beyond five years drops to...
http://www.azonano.com/news.aspx?newsID=20655 | 23 Nov 2010